BJH - volume 5, issue 4, december 2014
M.C. Vekemans MD, K. Beel MD, PhD, J. Caers MD, PhD, N. Meuleman MD, PhD, G. Bries MD, PhD, V. Delrieu MD, H. Demuynck MD, B. De Prijck MD, H. De Samblanx MD, A. Deweweire MD, A. Kentos MD, PhD, P. Mineur MD, F. Offner MD, PhD, I. Vande Broek MD, PhD, A. Vande Velde MD, J. Van Droogenbroeck MD, KL. Wu MD, PhD, C. Doyen MD, R. Schots MD, PhD, M. Delforge MD, PhD
With the introduction of immunomodulatory drugs and proteasome inhibitors, major improvements have been achieved in the treatment and prognosis of multiple myeloma. Different treatment combinations are now in use and innovative therapies are being developed. This rapidly changing therapeutic landscape calls for an update on the Belgian myeloma guidelines, published in 2010.1 Based on an extensive review of the recent literature, the myeloma study group of the Belgian Hematology Society has revised the consensus recommendations on myeloma care, to be used by haematologists as a reference for daily practice. When applicable, comments with regards to the Belgian reimbursement modalities are included. The full text with appendices can be downloaded from the Belgian Hematology Society website (www.bhs.be) and from the Belgium Journal of Hematology website (www.ariez.com).
(BELG J HEMATOL 2014;5(4):125–36)
Read moreBJH - volume 5, issue Abstract Book BHS, january 2014
A. De Cuyper , R. Galot , A. Ferrant , D. Latinne , L. Knoops MD, PhD, L. Michaux MD, PhD, V. Havelange MD, PhD, M.C. Vekemans MD, C. Lambert MD, PhD, E. Van den Neste MD, PhD, X. Poiré MD, PhD
BJH - volume 5, issue Abstract Book BHS, january 2014
F. Van Obbergh MD, A. Ferrant , D. Wilmes , J. Yombi , L. Knoops MD, PhD, M.C. Vekemans MD, L. Michaux MD, PhD
BJH - volume 5, issue Abstract Book BHS, january 2014
J. Caers MD, PhD, M.C. Vekemans MD, I. Vande Broek MD, PhD, V. Maertens MD, P.H. Mineur , G. Bries MD, PhD, E. Vandeneste , G. Vanstraelen , K. Beel MD, PhD, F. Leleu , H. Demuynck MD, C. Scheurmans , A. Van De Velde MD, PhD, W. Schroyens MD, PhD, K.L. Wu MD, PhD, N. Meuleman MD, PhD, R. Schots MD, PhD, M. Delforge MD, PhD, C. Doyen MD
BJH - volume 5, issue Abstract Book BHS, january 2014
C. Katoto , J. De Greef , S. Bailly MD, X. Poiré MD, PhD, T. Duprez , E. Van De Neste , V. Havelange MD, PhD, L. Michaux MD, PhD, M.C. Vekemans MD
BJH - volume 5, issue Abstract Book BHS, january 2014
A. Dermine , J. Devreux , J.P. Cosyns , P. Saussoy MD, PhD, L. Labriola , M. Mourad , L. Michaux MD, PhD, X. Poiré MD, PhD, V. Havelange MD, PhD, M.C. Vekemans MD
BJH - volume 5, issue Abstract Book BHS, january 2014
J. De Greef , S. Bailly MD, P.D.M. Katoto , P. Van den Bergh , X. Poiré MD, PhD, L. Michaux MD, PhD, V. Havelange MD, PhD, M.C. Vekemans MD
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
